Patents Assigned to Sanofi
  • Patent number: 11865307
    Abstract: A medicament injection device comprising a main body arranged to receive a medicament cartridge; a needle carrier carrying a needle, wherein the needle carrier is axially movable with respect to the main body; and a rotatable cap at a distal end of the device, wherein the cap is removably coupled to the needle carrier, a releasable arrangement between the main body and the cap comprising a guide element and a slotted link, wherein the slotted link is arranged to cause the guide element to follow a predefined path at least partly in an axial direction during rotational movement of the cap, thereby causing the needle carrier to move axially towards a proximal end of the device as the cap is rotated up to a predefined point, wherein the main body comprises a medicament cartridge holder comprising the guide element depending therefrom for engagement with the cap.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: January 9, 2024
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Marc Schader, Michael Helmer, Peter Nober, Michael Varga
  • Patent number: 11865318
    Abstract: The present disclosure relates to an injection device configured to expel a dose of a medicament, the injection device comprising: an elongated housing extending in a longitudinal direction, a piston rod movable relative to the housing in a longitudinal distal direction to exert a dispensing pressure onto a bung of a cartridge at least partially filled with an injectable medicament, a rod extension movably arranged on or in a distal end of the piston rod, a driver operably engaged with the piston rod and movable relative to the housing in a longitudinal proximal direction for setting of the dose and movable relative to the housing in the longitudinal distal direction for dispensing of the dose, and an adjuster arranged on or in the driver and operably engaged with the rod extension to move the rod extension in longitudinal direction relative to the piston rod.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: January 9, 2024
    Assignee: Sanofi
    Inventors: Michael Jugl, Stefan Blancke
  • Patent number: 11865315
    Abstract: A feedback mechanism for an injection device that is configured to deliver a medicament to a user is described. The feedback mechanism comprises an actuator and a fluid chamber having a restricted outlet. The actuator is adapted to urge fluid from the fluid chamber through the restricted outlet. The feedback mechanism also has an indicator that is adapted to provide feedback to the user after a predetermined volume of fluid has passed from the fluid chamber through the restricted outlet during use of the injection device.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 9, 2024
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Marc Schader, Matthias Rau, Sebastian Braun
  • Patent number: 11865308
    Abstract: A medicament injection device comprising a main body arranged to receive a medicament cartridge; a needle carrier carrying a needle, wherein the needle carrier is axially movable with respect to the main body; and a rotatable cap at a distal end of the device, wherein the cap is removably coupled to the needle carrier, a releasable arrangement between the main body and the cap comprising a guide element and a slotted link, wherein the slotted link is arranged to cause the guide element to follow a predefined path at least partly in an axial direction during rotational movement of the cap, thereby causing the needle carrier to move axially towards a proximal end of the device as the cap is rotated up to a predefined point, wherein the main body comprises a medicament cartridge holder comprising the guide element depending therefrom for engagement with the cap.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: January 9, 2024
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Marc Schader, Michael Helmer, Peter Nober, Michael Varga
  • Patent number: 11865312
    Abstract: Described is a dose tracking mechanism for a drug delivery device, including a moveable component configured to move with respect to a housing during operation of the drug delivery device and an RFID device with an electric circuit having a resonance frequency. The electric circuit includes an antenna configured to transmit a wireless RFID signal at the resonance frequency and an electrical component operatively coupled to the moveable component and configured to modify the resonance frequency based on a position of the moveable component, such that the resonance frequency of the electric circuit is an indication of the position of the moveable component. In some instances, the position of the moveable component indicates a dose set or dispensed from the drug delivery device.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: January 9, 2024
    Assignee: Sanofi
    Inventors: Markus Ploch, Maurice Toporek
  • Patent number: 11865311
    Abstract: A handheld injection device includes a housing containing a cartridge, a dose setting means being operable in a first direction to set a desired dose to be dispensed, a piston rod being adapted to cooperate with a piston so as to cause a set dose to be injected from the cartridge, and a first clicker component, which is largely rotationally constrained to the housing, and a second clicker component, which is rotatable relative to the housing during dose dispensing. The clicker components are adapted to contact each other only at the end of dispensing of a set dose to thereby provide an audible and/or tactile first feedback to a user. The first clicker component is displaceable relative to the housing between a proximal dose setting position and a distal dose dispensing position.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: January 9, 2024
    Assignee: Sanofi
    Inventor: Anthony Paul Morris
  • Publication number: 20240002950
    Abstract: The present disclosure relates to a panel of ER regulated genes and method for using the panel for monitoring the response of an individual having cancer to treatment with amcenestrant, the method comprising determining a first ER activity score from a sample from the individual at a first time point before treatment with amcenestrant using the panel, then determining a second ER activity score from a sample from the individual at a second time point following administration of amcenestrant using the panel, and comparing the first ER activity score with the second ER activity score, wherein a decrease in the second ER activity score relative to the first ER activity score is predictive of target engagement of amcenestrant.
    Type: Application
    Filed: November 22, 2021
    Publication date: January 4, 2024
    Applicant: Sanofi
    Inventors: Monsif Bouaboula, Hui Cao, Joon Sang Lee, Vasiliki Pelekanou, Maysoun Shomali
  • Patent number: 11862331
    Abstract: An apparatus is disclosed, comprising a detector unit comprising a detector configured to detect an actuation action performable via the detector unit to an actuation button of a medical device to cause the medical device to eject at least a portion of a medicament comprised in the medical device. The detector is configured to detect the actuation action based on a detection of a force and/or a touch applied to the detector unit as part of the actuation action. The apparatus further comprises an electric unit connected to the detector and configured to store and/or provide information related to the detected actuation action. Furthermore, an according method and a computer program for controlling this method are disclosed.
    Type: Grant
    Filed: May 13, 2021
    Date of Patent: January 2, 2024
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Jasmin Groeschke, Hanno Juhnke, Jan-Peter Spengler, Matthias Scharf, Christoph Dette, Michael Schrack, Olaf Zeckai
  • Patent number: 11857708
    Abstract: A supplementary device configured to be attached to a drug delivery device, the supplementary device including: first means being adapted to mechanically couple the supplementary device to a dosage selector of the drug delivery device; second means being adapted to select a dosage to be delivered by the drug delivery device; third means being adapted to mechanically couple the second means to the first means such that a dosage selection made with the second means generates a torque being transferred via the third means to the first means; a sensor configured to output signals indicative of the generated torque; and electronics configured to receive the signals output from the sensor and to determine based on the signals the selected dosage.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: January 2, 2024
    Assignee: Sanofi
    Inventors: Michael Helmer, Christian Rehbein
  • Patent number: 11857325
    Abstract: A device for communicating a driving ability level of a user, the device comprising at least a processor, a memory, and a wireless transceiver. The device is configured to: receive a communication from a medical device, wherein the communication comprises information relating to a condition of the medical device; and send a communication to a vehicle. The information relating to a condition of the medical device is processed in order to determine a driving ability level of the user by the assignment of a category selected from a group comprising a first category and a second category.
    Type: Grant
    Filed: August 3, 2022
    Date of Patent: January 2, 2024
    Assignee: Sanofi
    Inventor: Michael Helmer
  • Patent number: 11854681
    Abstract: A data management unit for supporting health control, the unit including: a processor, a data input adapted to input data and/or requests and connected to the processor, a data storage connected to the processor, wherein the processor is adapted to assign a tag referring to an event chosen from a group of tags comprising the fasting tag and at least one other event tag to a new data received from the data input or a measurement unit, wherein the tag is assigned either automatically by the processor and/or via the data input, wherein the fasting tag can only be assigned to the new data if a time stamp of the new data is within a predefined fasting window, wherein the predefined fasting window is stored in the data storage.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: December 26, 2023
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Axel Teucher, Florian Schauderna, Jochen Sieber, Alexandra Beer, Frank Roethke, Frank Flacke, Andrew Tubb, Ashley Engelhardt, Joseph Pomata, Margaret Wiley, Thora Thorgilsdottir, Alyssa Rosenzweig
  • Patent number: 11850405
    Abstract: A supplementary device for attachment to a drug delivery device is provided. The device includes an attachment mechanism for coupling the supplementary device to the drug delivery device, an imaging arrangement for providing image data representing a captured image of one or more numbers present on a number sleeve of the drug delivery device and a processor arrangement. The processor arrangement is configured to receive the image data; perform optical character recognition on the image data to determine a quantity of a currently set dose of medicament; cause display of the quantity of the currently set dose; process the image data to identify one or more characteristics of the number sleeve; determine from the identified characteristics whether the currently set dose is a permitted dose; and if the currently set dose is not a permitted dose, cause an indication that the currently set dose is not a permitted dose.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: December 26, 2023
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventor: Stephan Riedel
  • Publication number: 20230404971
    Abstract: Herein are provided a combination of abemaciclib and of 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing such a combination, and the therapeutic uses thereof, in particular for the treatment of cancer, including breast cancer.
    Type: Application
    Filed: November 23, 2021
    Publication date: December 21, 2023
    Applicant: Sanofi
    Inventors: Monsif Bouaboula, Zhuyan Guo, Fangxian Sun
  • Patent number: 11844936
    Abstract: The present invention relates to a medicament delivery device, comprising an outer body, a receptacle for a medicament, a needle for the administration of the medicament, an injection mechanism with an actuating mechanism for injecting the medicament into the patients body, and a needle guard for the needle. The medicament delivery device further comprising a detecting element for the detection of the orientation of the medicament delivery device, and a locking mechanism releasing the actuating mechanism, if the detecting element is in the at least first position, and locking the actuating mechanism, if the detecting element is in the at least second position, wherein the locking mechanism is controlled and/or actuated by the detecting element.
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: December 19, 2023
    Assignee: Sanofi
    Inventor: Stephan Riedel
  • Patent number: 11845800
    Abstract: The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: December 19, 2023
    Assignees: SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS, INC.
    Inventors: Marius Ardeleanu, Namita A. Gandhi, Neil Graham, Stephane C. Kirkesseli, Sudeep Kundu, Ross E. Rocklin, Allen Radin, Steven P. Weinstein, Jennifer Davidson Hamilton, Jeffrey Ming
  • Publication number: 20230398211
    Abstract: The present invention relates to a liposome comprising a saponin, a sterol, a phospholipid and a Toll-like receptor 4 (TLR4) agonist of formula (I), to methods of preparing liposomes, to compositions comprising them and to uses thereof, and to immunogenic compositions comprising such liposomes as adjuvant.
    Type: Application
    Filed: October 28, 2021
    Publication date: December 14, 2023
    Applicant: Sanofi Pasteur
    Inventors: Marie Garinot, Jean Haensler, Fabienne Piras, Patrick Syntin, Sophie Ruiz
  • Patent number: 11839750
    Abstract: The present invention relates to an injection device that includes a housing having an axis, and a needle sleeve that is axially movably within the housing. Axial movement of the needle sleeve into the housing is configured to actuate an injection process. The needle sleeve includes a first part that is slidably mounted to the housing, and a second part that protrudes from the housing and is rotationally coupled to the first part. The needle sleeve includes a locking mechanism that is configured to prevent axial movement of the needle sleeve into the housing until the second part of the needle sleeve has been rotated relative to the first part of the needle sleeve.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: December 12, 2023
    Assignee: Sanofi
    Inventors: Beate Franke, Ulrich Brueggemann, Matthias Rau, Jeff Kablik
  • Patent number: 11840566
    Abstract: The present technology aims at providing a novel type of drug for treating a subject suffering from an inflammatory disease. Specifically, the present technology provides polypeptides comprising at least four immunoglobulin single variable domains (ISVDs), characterized in that at least two ISVDs bind to IL-13 and at least two ISVDs binds to TSLP. The present technology also provides nucleic acids, vectors and compositions.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: December 12, 2023
    Assignees: Ablynx N.V., Sanofi
    Inventors: Heidi Rommelaere, Ann Brigé, Sigrid Cornelis, Bruno Dombrecht, Eric Lorent, Melanie Rieger, Timothy Soos, John Park, Bernd Weigle, Klaus Erb
  • Patent number: 11833338
    Abstract: An injector device includes a housing and a cartridge having a reservoir for medicament. The injector device further includes a needle unit comprising a needle, and an actuator. The needle unit is movably mounted to the housing and, prior to use of the injector device the reservoir, is sealed from the needle. The actuator is configured to move the needle unit into engagement with the cartridge such that the needle is moved into fluid communication with the reservoir. A thread is arranged to cause rotation of the needle unit as the needle unit moves into engagement with the cartridge.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: December 5, 2023
    Assignee: Sanofi
    Inventors: Beate Franke, Ulrich Brueggemann, Jeff Kablik
  • Patent number: 11833331
    Abstract: According to the invention, an auto-injector for administering a dose of a liquid medicament (M) comprises of a substantially cylindrical housing arranged to contain a pre-filled syringe filled with the medicament (M), a needle shroud slibably arranged with respect to the housing and adapted to rest on the skin of a patient receiving an injection, a releasable drive means arranged within the housing that is capable of, upon release, translating the needle shroud in a proximal direction (P) towards a safe position (PS) and a rotating collar rotatably arranged within the housing. The needle shroud in the safe position (PS) surrounds the injection needle after the injection has been carried out. The rotating collar engages the needle shroud in a manner that forces the rotating collar to rotate within the housing when the needle shroud is translated in the proximal direction (P).
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: December 5, 2023
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Yannick Hourmand, Timothy Donald Barrow-Williams, Matthew Ekman